Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis (vol 14, pg 983, 2024)


Por: Torres, T, Petersen, AS, Ivens, U, Vilaro, AB, Stinson, J and Carrascosa, JM

Publicada: 1 feb 2025 Ahead of Print: 1 ene 2025
Resumen:


Filiaciones:
Torres, T:
 Univ Porto, CHU Santo Antonio, Porto, Portugal

Petersen, AS:
 LEO Pharm AS, Industriparken 55, DK-2750 Ballerup, Denmark

Ivens, U:
 LEO Pharm AS, Industriparken 55, DK-2750 Ballerup, Denmark

Vilaro, AB:
 LEO Pharm AS, Industriparken 55, DK-2750 Ballerup, Denmark

Stinson, J:
 LEO Pharm AS, Industriparken 55, DK-2750 Ballerup, Denmark

:
 UAB, Hosp Univ Germans Trias I Pujol, IGTP, Badalona, Spain
ISSN: 21938210





Dermatology and Therapy
Editorial
Springer Verlag, 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND, Reino Unido
Tipo de documento: Correction
Volumen: 15 Número: 2
Páginas: 473-475
WOS Id: 001398325000001
ID de PubMed: 39821857
imagen Green Submitted, gold

MÉTRICAS